| Accession Number: | 0001562180-21-007534 |
| Date: | 2021-12-02 |
| Issuer: | HEALTH CATALYST, INC. (HCAT) |
| Original Submission Date: |
ALGER JASON
C/O HEALTH CATALYST, INC.
10897 SOUTH RIVER FRONT PARKWAY, #300
SOUTH JORDAN, UT 84095
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2021-12-02 | F | 1,460 | d | $41.95 | 13,852 | direct | ||
| COMMON STOCK | 2021-12-06 | S | 644 | d | $38.83 | 13,208 | direct |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|
| ID | footnote |
|---|---|
| f1 | represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of issuer's restricted stock units. this sale is mandated by the issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. |
| f2 | represents a weighted average price reported by the broker. these shares were sold as part of a block trade in multiple transactions at prices ranging from $40.33 to $42.76, inclusive. the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote with regard to the block trade. |
| f3 | the sale reported on this form 4 was made pursuant to a written trading plan adopted by the reporting person on december 15, 2020, in accordance with rule 10b5-1. |
